IDEAYA Biosciences, Inc. (IDYA) Q1 2021 Earnings Results

IDEAYA Biosciences I Beats on EPS, Stock Up 1.25%

IDEAYA Biosciences I's earnings report shows a positive surprise on EPS, indicating better-than-expected performance in that area. The stock reacted positively, rising by 1.25%. However, the lack of revenue data and guidance may leave investors cautious about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.28	N/A	+0.36%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the current progress of their projects. They emphasized their commitment to pipeline advancement despite not providing specific guidance.

We are pleased with our progress in the quarter.

Our focus remains on advancing our pipeline.

IDEAYA Biosciences I Beats on EPS, Stock Up 1.25%

Key numbers

Management commentary

IDEAYA Biosciences, Inc.

More earnings this week

IDEAYA Biosciences I Beats on EPS, Stock Up 1.25%

Key numbers

Management commentary